Phase II Study of Durvalumab ,Doxorubicin, and Ifosfamide in Pulmonary Sarcomatoid Carcinoma
Seoul National University Hospital
Seoul National University Hospital
Azienda USL Reggio Emilia - IRCCS
UNICANCER
Ziekenhuis Oost-Limburg
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Alabama at Birmingham
European Lung Cancer Working Party
Aktion Bronchialkarzinom e.V.